LightLab Imaging, Inc. – Trademark Portfolio
Entity Type: 03
LightLab Imaging, Inc. holds 34 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 30 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 11 trademarks are registered. Notable registered marks include OPTIS, ILUMIEN, DRAGONFLY, DRAGONFLY DUO, and ILUMIEN OPTIS. The owner is based in Sylmar, CA.
15900 Valley View Court
Sylmar, CA 913929221
Showing of trademarks Trademarks
Trademark Classifications
LightLab Imaging, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does LightLab Imaging, Inc. have?
LightLab Imaging, Inc. has 34 U.S. trademarks filed with the USPTO. Of these, 11 registered, 15 abandoned, 8 cancelled.
What trademark classes does LightLab Imaging, Inc. file in?
LightLab Imaging, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are LightLab Imaging, Inc.'s most well-known trademarks?
LightLab Imaging, Inc.'s registered trademark portfolio includes well-known marks such as OPTIS, ILUMIEN, DRAGONFLY, DRAGONFLY DUO, and ILUMIEN OPTIS. These are among 11 currently registered trademarks in the portfolio.
What is LightLab Imaging, Inc.'s trademark registration success rate?
LightLab Imaging, Inc. has a 32% trademark registration rate, with 11 out of 34 resolved applications resulting in successful registration. Currently, 0 applications are pending review.